Results 21 to 30 of about 499,109 (301)
Pharmaceuticals, 2021 Designer benzodiazepines (DBZDs) represent a serious health concern and are increasingly reported in polydrug consumption-related fatalities. When new DBZDs are identified, very limited information is available on their pharmacodynamics.
Valeria Catalani +6 more
doaj +1 more source
Pharmaceuticals, 2022 Despite increasing reports, antidepressant (AD) misuse and dependence remain underestimated issues, possibly due to limited epidemiological and pharmacovigilance evidence.
Stefania Chiappini +5 more
doaj +1 more source
The use of psychoactive substances in Germany
Deutsches Ärzteblatt international, 2022 Monitoring the use of psychoactive substances and substance-related problems in the population allows for the assessment of prevalence and associated health and social consequences.The data are derived from the Epidemiological Survey of Substance Abuse (ESA) 2021 (n = 9046, 18-64 years).
Christian, Rauschert +5 more
openaire +2 more sources
Screening Unknown Novel Psychoactive Substances Using GC-MS Based Machine Learning [PDF]
, 2022 In recent years, there is a large increase in structural diversity of novel psychoactive substances (NPS), exacerbating drug abuse issues as these variants evade classical detection methods such as spectral library matching.
Swee Liang, Wong +3 more
core +1 more source
Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoamine signalling [PDF]
, 2015 Novel psychoactive substances are newly used designer drugs ("internet drugs", "research chemicals", "legal highs") potentially posing similar health risks to classic illicit substances. Chemically, many novel psychoactive substances can be classified as
Liechti, Matthias E., Matthias Liechti
core +1 more source
Pharmacology of novel psychoactive substances [PDF]
, 2016 This PhD work consists of an in vitro and in vivo part. In the in vivo part, we investigated the role of dopamine in the acute clinical effects of 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) in healthy human subjects.
Rickli, Anna
core +1 more source
Brain Sciences, 2018 Recently, a range of prescription and over-the-counter drugs have been reportedly used as Novel Psychoactive Substances (NPS), due to their potential for abuse resulting from their high dosage/idiosyncratic methods of self-administration.
Fabrizio Schifano +3 more
doaj +1 more source
Novel Psychoactive Substances and Behavioral Addictions [PDF]
BioMed Research International, 2014 Copyright © 2014 Giovanni Martinotti et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Giovanni Martinotti +3 more
openaire +7 more sources
Head shops and new psychoactive substances: a public health perspective.
, 2023 In 2010, Ireland found itself at the eye of an international storm as a network of head shops emerged selling new psychoactive substances (NPS) and Irish youth rapidly became the heaviest users of NPS in Europe.
Smyth, Bobby P
core +1 more source
Legal approaches to new psychoactive substances: first empirical findings.
, 2023 BACKGROUND: Generic drug legislation, i.e., simultaneously banning groups of drugs, has been introduced worldwide to counteract the trade and use of emerging "new psychoactive substances" (NPSs) more effectively.
van Amsterdam, Jan +2 more
core +1 more source